<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Ovarian Res</journal-id>
      <journal-id journal-id-type="iso-abbrev">J Ovarian Res</journal-id>
      <journal-title-group>
        <journal-title>Journal of Ovarian Research</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1757-2215</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25297715</article-id>
      <article-id pub-id-type="pmc">4172858</article-id>
      <article-id pub-id-type="publisher-id">88</article-id>
      <article-id pub-id-type="doi">10.1186/s13048-014-0088-0</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Molecular pathogenesis in granulosa cell tumor is not only due to somatic <italic>FOXL2</italic> mutation</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>Wen-Chung</given-names>
          </name>
          <address>
            <email>leopard.wang@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Lai</surname>
            <given-names>Yen-Chein</given-names>
          </name>
          <address>
            <email>yenchein@csmu.edu.tw</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <aff id="Aff1"><label/>Department of Obstetrics and Gynecology, Jen-Ai Hospital, Taichung, Taiwan </aff>
        <aff id="Aff2"><label/>School of Medical Laboratory and Biotechnology, Chung Shan Medical University, No.110, Sec. 1, Chien Kuo N. Road, Taichung, 402 Taiwan </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>6</day>
        <month>9</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>6</day>
        <month>9</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2014</year>
      </pub-date>
      <volume>7</volume>
      <elocation-id>88</elocation-id>
      <history>
        <date date-type="received">
          <day>1</day>
          <month>4</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>31</day>
          <month>8</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Wang and Lai; licensee BioMed Central Ltd. 2014</copyright-statement>
        <license license-type="open-access">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <p>Granulosa cell tumors are rare ovarian malignancies. Their characteristics include unpredictable late recurrent and malignant behavior. Recent molecular studies have characterized the <italic>FOXL2</italic> 402C&#x2009;&gt;&#x2009;G mutation in adult-type granulosa cell tumor. In this study, we report an 80-year-old woman with a granulosa cell tumor arising from ovary. She presented with a huge pelvic mass with postmenopausal bleeding. No obvious intraperitoneal tumor implants were observed during operation. Final diagnosis was granulosa-theca cell tumor without capsule invasion. No recurrent disease was noted during 3-year post-operation follow-up period. Molecular studies showed a heterozygous <italic>FOXL2</italic> 402C&#x2009;&gt;&#x2009;G mutation in the tumor by direct gene sequencing. In addition, DNA replication error, on analysis of the lengths of CAG repeats in androgen receptor gene, revealed defective DNA mismatch repair system in the granulosa cell tumor. We propose that the 402C&#x2009;&gt;&#x2009;G mutation in FOXL2 is critical to the development of adult granulosa cell tumor. However, the malignant behavior of this tumor is driven by DNA mismatch repair deficiency. Unequal DNA copy numbers were noted on array comparative genomic hybridization. This implies that there is malignant potential even in the early stage of the granulosa cell tumor. Late malignant recurrence may be a late event of DNA repair function disability, not directly related to pathognomonic <italic>FOXL2</italic> mutation.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Granulosa cell tumor</kwd>
        <kwd><italic>FOXL2</italic> mutation</kwd>
        <kwd>Loss of heterozygosity</kwd>
        <kwd>Array comparative genomic hybridization</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2014</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Background</title>
      <p>Sex cord-stromal tumors represent approximately 8% of all ovarian tumors [<xref ref-type="bibr" rid="CR1">1</xref>]. The incidence is about 0.2 per 100000 women. The most frequently diagnosed tumor type within sex cord-stromal category is the granulosa cell tumor [<xref ref-type="bibr" rid="CR1">1</xref>]. Granulosa cell tumors may be composed almost exclusively of granulosa cells, but more commonly also contain theca cells, lutein cells, and/or fibroblasts [<xref ref-type="bibr" rid="CR2">2</xref>]. The granulosa cells in tumor may be arranged in trabecular, insular, grand like, microfollicular, macrofollicular or diffuse cellular patterns [<xref ref-type="bibr" rid="CR3">3</xref>]. Granulosa cell tumors can be further categorized into two distinct subtypes, juvenile and adult forms [<xref ref-type="bibr" rid="CR1">1</xref>]. Juvenile granulosa cell tumor is characterized by a modular or diffuse pattern, with follicle-like spaces of variable size and shape and striking cytologic atypia [<xref ref-type="bibr" rid="CR3">3</xref>]. In some cases, these tumors cannot be distinguished from each other or from other malignant tumors. Recent studies of <italic>FOXL2</italic> (forkhead box L2) gene 402C&#x2009;&gt;&#x2009;G (C134W) mutation may resolve the problems of adult-type granulosa cell tumor diagnosis [<xref ref-type="bibr" rid="CR4">4</xref>]. Adult-type granulosa cell tumors are much more common and mostly occur in perimenopausal or early postmenopausal females [<xref ref-type="bibr" rid="CR5">5</xref>].</p>
      <p>Granulosa cell tumors are generally considered to have a better prognosis than epithelial ovarian tumors [<xref ref-type="bibr" rid="CR1">1</xref>]. However, there is high rate of tumor recurrence late in life and approximately 80% of patients with advanced stage or recurrent tumors succumb to their disease [<xref ref-type="bibr" rid="CR6">6</xref>]. Granulosa cell tumors with malignant potential comprise 1.0 percent of all ovarian cancers [<xref ref-type="bibr" rid="CR1">1</xref>]. The characteristics associated with granulosa cell tumors cannot be explained by ploidy or p53 overexpression [<xref ref-type="bibr" rid="CR7">7</xref>,<xref ref-type="bibr" rid="CR8">8</xref>].</p>
    </sec>
    <sec id="Sec2">
      <title>Case report</title>
      <p>An 80-year-old woman presented with a clinically detectable pelvic mass. She subsequently underwent laparotomy for total hysterectomy and bilateral salpingo-oophorectomy. Gross examination demonstrated an ovarian mass with attached fallopian tube, measuring 11.0 &#xD7; 8.0 &#xD7; 7.0&#xA0;cm, which was brownish in color and elastic. On cut, the ovary was yellowish in color and soft. Microscopically, the ovary revealed a granulosa-theca cell tumor characterized by granulosa cells in trabecular or cylindrical pattern and theca cells in spindle pattern (Figure&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>). FIGO stage IA was supported by pathological report. Her blood inhibin A and B levels were 47.208&#xA0;pg/ml and 92.473&#xA0;pg/ml, respectively, immediately after operation and 15.533&#xA0;pg/ml and 22.331&#xA0;pg/ml, respectively, one month post-operation. No recurrent disease was noted during 3-year post-operation follow-up period. The Institutional Review Board of Chung Shan Medical University Hospital approved all procedures and informed consent was obtained prior to collecting her genetic material for the study.<fig id="Fig1"><label>Figure 1</label><caption><p>
<bold>Granulosa cell tumor: Histological cross-section after hematoxylin and eosin staining shows the adult granulosa cell tumor component.</bold>
</p></caption><graphic xlink:href="13048_2014_88_Fig1_HTML" id="MO1"/></fig></p>
      <p>We tested for the presence of <italic>FOXL2</italic> 402C&#x2009;&gt;&#x2009;G mutation using PCR and direct sequencing according to the methods described by Schrader et al [<xref ref-type="bibr" rid="CR9">9</xref>]. The nucleotide sequence analysis of <italic>FOXL2</italic> from the granulosa cell tumor section revealed heterozygous 402C&#x2009;&gt;&#x2009;G mutation. In contrast, <italic>FOXL2</italic> sequences of genomic DNA isolated from the blood and normal tissue of this patient did not demonstrate this mutation. When compared with DNA from normal cells (Figure&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>A), DNA replication error caused by slippage between the replication apparatus and the DNA template was detected in the granulosa cell tumor (Figure&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>B), on analysis of the lengths of CAG repeats in androgen receptor gene, using published primers and experimental conditions [<xref ref-type="bibr" rid="CR10">10</xref>]. In addition, we compared the DNA profiles of normal tissue and tumor tissue using short tandem repeats (STR) analysis according to the methods described by Wang et al [<xref ref-type="bibr" rid="CR11">11</xref>]. The tumor showed loss of heterozygosity (LOH) for a number of markers (Figure&#xA0;<xref rid="Fig3" ref-type="fig">3</xref> and Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>). Moreover, based on array comparative genomic hybridization (CGH), pathological genetic imbalances were detected in the tumor on CytoChip Oligo Array (BlueGenome): monosomy 4 and 10; partial monosomy 14 with segmental deletions; and mosaic trisomy 6, 11, 12, 13, 15, and 18 with segmental duplications (Figure&#xA0;<xref rid="Fig4" ref-type="fig">4</xref> and Table&#xA0;<xref rid="Tab2" ref-type="table">2</xref>).<fig id="Fig2"><label>Figure 2</label><caption><p>
<bold>Replication error was detected on analysis of the CAG repeats in androgen receptor gene by capillary gel electrophoresis.</bold> DNA from tumor <bold>(B)</bold> is compared with DNA from normal cells <bold>(A)</bold> from the same patient.</p></caption><graphic xlink:href="13048_2014_88_Fig2_HTML" id="MO2"/></fig><fig id="Fig3"><label>Figure 3</label><caption><p>
<bold>LOH for a number of markers: Selective electrophoregram of the DNA profiles of blood and tumor tissue using short tandem repeats (STR) analysis with AmpFlSTR SGM Plus PCR amplification kit.</bold> Colored panels are representative of the following: <bold>(A)</bold> STR loci of D8S1179, D21S11, D7S820, and CSF1PO; <bold>(B)</bold> STR loci of D19S433 and vWA; <bold>(C)</bold> STR loci of D3S1358 and D2S1338.</p></caption><graphic xlink:href="13048_2014_88_Fig3_HTML" id="MO3"/></fig><table-wrap id="Tab1"><label>Table 1</label><caption><p>
<bold>Loss of heterozygosity in 15 STR loci of the granulosa cell tumor</bold>
</p></caption><table frame="hsides" rules="groups"><thead><tr valign="top"><th>
<bold>STR Loci</bold>
</th><th>
<bold>Location</bold>
</th><th>
<bold>Alleles</bold>
</th><th>
<bold>R</bold>
<sup><bold>a</bold></sup>
</th></tr></thead><tbody><tr valign="top"><td>TPOX</td><td>2p23-2per</td><td>8, 8</td><td>ND</td></tr><tr valign="top"><td>D2S1338</td><td>2q35-37.1</td><td>22, 23</td><td>1.63<sup>b</sup>
</td></tr><tr valign="top"><td>D3S1358</td><td>3p21.31</td><td>15, 16</td><td>1.84<sup>b</sup>
</td></tr><tr valign="top"><td>FGA</td><td>4q28</td><td>22, 23</td><td>1.01</td></tr><tr valign="top"><td>D5S818</td><td>5q21-31</td><td>11, 11</td><td>ND</td></tr><tr valign="top"><td>CSF1PO</td><td>5q33.3-34</td><td>10, 11</td><td>1.86<sup>b</sup>
</td></tr><tr valign="top"><td>D7S820</td><td>7q11.21-22</td><td>10, 12</td><td>0.56<sup>b</sup>
</td></tr><tr valign="top"><td>D8S1179</td><td>8q24.1-24.2</td><td>11, 11</td><td>ND</td></tr><tr valign="top"><td>TH01</td><td>11p15.5</td><td>9, 9</td><td>ND</td></tr><tr valign="top"><td>vWA</td><td>12p12-pter</td><td>14, 18</td><td>1.14</td></tr><tr valign="top"><td>D13S317</td><td>13q22-31</td><td>10, 13</td><td>0.94</td></tr><tr valign="top"><td>D16S539</td><td>16q24-qter</td><td>9, 11</td><td>1.11</td></tr><tr valign="top"><td>D18S51</td><td>18q21.3</td><td>14, 18</td><td>1.06</td></tr><tr valign="top"><td>D19S433</td><td>19q12-13.1</td><td>13, 14</td><td>1.81<sup>b</sup>
</td></tr><tr valign="top"><td>D21S11</td><td>21q11.2-q21</td><td>30, 31.2</td><td>2.12<sup>b</sup>
</td></tr></tbody></table><table-wrap-foot><p>
<sup>a</sup>R&#x2009;=&#x2009;(area T1/area T2)/(area N1/area N2); <sup>b</sup>Loss of heterozygosity (LOH) is positive when R&#x2009;&#x2265;&#x2009;1.25 or&#x2009;&#x2264;&#x2009;0.8 (ie., 20% change).</p></table-wrap-foot></table-wrap><fig id="Fig4"><label>Figure 4</label><caption><p>
<bold>Array comparative genomic hybridization (aCGH) analysis: Whole genome view on comparative genomic hybridization array (CytoChip Oligo Array) shows pathological genetic imbalances in many chromosomes in the tumor.</bold>
</p></caption><graphic xlink:href="13048_2014_88_Fig4_HTML" id="MO4"/></fig><table-wrap id="Tab2"><label>Table 2</label><caption><p>
<bold>The deleted or duplicated clones and their physical location in the granulosa cell tumor</bold>
</p></caption><table frame="hsides" rules="groups"><thead><tr valign="top"><th/><th>
<bold>ISCN nomenclature</bold>
</th><th>
<bold>Type</bold>
</th><th>
<bold>Size (bp)</bold>
</th></tr></thead><tbody><tr valign="top"><td>1</td><td>arr 4p16.3q35.2(37,152-190,896,645)&#xD7;1</td><td>LOSS</td><td>190,859,493</td></tr><tr valign="top"><td>2</td><td>arr 6p25.3q27(163,113-170,921,060)&#xD7;2&#x2009;~&#x2009;3</td><td>GAIN</td><td>170,757,947</td></tr><tr valign="top"><td>3</td><td>arr 10p15.3q26.3(136,391-135,434,149)&#xD7;1</td><td>LOSS</td><td>135,297,758</td></tr><tr valign="top"><td>4</td><td>arr 11p15.5q25(196,990-134,868,378)&#xD7;2&#x2009;~&#x2009;3</td><td>GAIN</td><td>134,671,388</td></tr><tr valign="top"><td>5</td><td>arr 12p13.33q24.33(230,451-133,773,499)&#xD7;2&#x2009;~&#x2009;3</td><td>GAIN</td><td>133,543,048</td></tr><tr valign="top"><td>6</td><td>arr 13q12.11q34(20,407,324-115,092,619)&#xD7;2&#x2009;~&#x2009;3</td><td>GAIN</td><td>94,685,295</td></tr><tr valign="top"><td>7</td><td>arr 14q11.2q32.33(20,608,246-107,287,476)&#xD7;1</td><td>LOSS</td><td>86,679,230</td></tr><tr valign="top"><td>8</td><td>arr 15q11.1q26.3(20,686,219-102,383,444)&#xD7;2&#x2009;~&#x2009;3</td><td>GAIN</td><td>81,697,225</td></tr><tr valign="top"><td>9</td><td>arr 16q11.2q24.3(46,500,771-90,148,364)&#xD7;1&#x2009;~&#x2009;2</td><td>LOSS</td><td>43,647,593</td></tr><tr valign="top"><td>10</td><td>arr 18p11.32q23(148,993-78,012,800)&#xD7;2&#x2009;~&#x2009;3</td><td>GAIN</td><td>77,863,807</td></tr></tbody></table></table-wrap></p>
    </sec>
    <sec id="Sec3" sec-type="discussion">
      <title>Discussion</title>
      <p>Recent studies have shown that <italic>FOXL2</italic> 402C&#x2009;&gt;&#x2009;G is a diagnostic characteristic of adult-type granulosa cell tumor [<xref ref-type="bibr" rid="CR4">4</xref>]. However, little is known about how a granulosa cell tumor undergoes indolent course with late recurrent behavior [<xref ref-type="bibr" rid="CR12">12</xref>]. We report a case of adult-type granulosa cell tumor with <italic>FOXL2</italic> 402C&#x2009;&gt;&#x2009;G mutation in an 80-year-old woman, in which one allele was normal and one was mutant. This mutation was not observed in the blood and normal tissue samples of this patient. Histological diagnosis is compatible with adult-type granulosa cell tumor in this case. RNA transcription arrays from granulosa cell tumor cell line have indicated that alteration involves cell death, proliferation and tumorigenesis [<xref ref-type="bibr" rid="CR13">13</xref>]. However, the mechanism is not clear.</p>
      <p>DNA replication error on analysis of the lengths of CAG repeats in androgen receptor gene (Figure&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>B) is consistent with a previous study suggesting that a DNA mismatch repair deficiency contributes to the pathogenesis of granulosa cell tumors, and that this deficiency is an early event in their development and/or progression [<xref ref-type="bibr" rid="CR14">14</xref>]. LOH for a number of markers (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref> and Figure&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>) and pathological genetic imbalances throughout the genome (Table&#xA0;<xref rid="Tab2" ref-type="table">2</xref> and Figure&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>) imply that a defective upstream regulatory gene is involved in this condition. The <italic>MLH1</italic> gene that encodes a component of the mismatch repair system located near the D3S1358 locus showed LOH (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>). This implies that the upstream regulatory mechanisms leading to increased DNA replication errors, LOH, and genetic imbalances are associated with defect(s) in global gene regulation.</p>
      <p>Our assumption is that a genetic alteration in mismatch repair system occurs before <italic>FOXL2</italic> 402C&#x2009;&gt;&#x2009;G mutation. After this mutation is initiated, granulosa cell tumor develops in early tumorigenesis. The genomic imbalances on array CGH in this study were inconsistent with the results of other array and CGH studies [<xref ref-type="bibr" rid="CR15">15</xref>]. However, there was a similar trend of genetic imbalances with a loss of 16q. These genetic imbalances may contribute to late tumorigenesis. Our hypothesis is that a DNA repair system failure induces <italic>FOXL2</italic> 402C&#x2009;&gt;&#x2009;G mutation, followed by granulosa cell tumor development. The same mechanism randomly causes further mutations of tumor suppressor genes or oncogenes, resulting in late recurrence and unpredictable malignant behavior of granulosa cell tumor. However, we cannot dismiss the possibility that the amino acid changing mutation in <italic>FOXL2</italic> 402C&#x2009;&gt;&#x2009;G is the driver mutation that leads to subsequent genomic alterations in granulosa cell tumor pathogenesis.</p>
    </sec>
    <sec id="Sec4" sec-type="conclusion">
      <title>Conclusions</title>
      <p>Adult-type granulosa cell tumors are associated with <italic>FOXL2</italic> 402C&#x2009;&gt;&#x2009;G mutation. In addition to this unique <italic>FOXL2</italic> mutation, we found DNA replication error and loss of heterozygosity in this case. DNA mismatch repair system failure appears likely in this patient. In such a case, early detection allows for treatment of benign tumor. Although this study could not elucidate the exact mechanism for the development of granulosa cell tumor, it does suggest the need to incorporate DNA mismatch repair system examination into the clinical management of patients with granulosa cell tumor.</p>
    </sec>
    <sec id="Sec5">
      <title>Consent</title>
      <p>Written informed consent was obtained from the patient for publication of this Case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.</p>
    </sec>
  </body>
  <back>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-list>
          <def-item>
            <term>aCGH</term>
            <def>
              <p>Array comparative genomic hybridization</p>
            </def>
          </def-item>
          <def-item>
            <term>FIGO</term>
            <def>
              <p>The International Federation of Gynecology and Obstetrics</p>
            </def>
          </def-item>
          <def-item>
            <term>
              <italic>FOXL2</italic>
            </term>
            <def>
              <p>Forkhead box L2</p>
            </def>
          </def-item>
          <def-item>
            <term>LOH</term>
            <def>
              <p>Loss of heterozygosity</p>
            </def>
          </def-item>
          <def-item>
            <term>
              <italic>MLH1</italic>
            </term>
            <def>
              <p>MutL homolog 1</p>
            </def>
          </def-item>
          <def-item>
            <term>PCR</term>
            <def>
              <p>Polymerase chain reaction</p>
            </def>
          </def-item>
          <def-item>
            <term>STR</term>
            <def>
              <p>Short tandem repeat</p>
            </def>
          </def-item>
        </def-list>
      </def-list>
    </glossary>
    <fn-group>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>The authors declare that they have no competing interests.</p>
      </fn>
      <fn>
        <p>
          <bold>Authors&#x2019; contributions</bold>
        </p>
        <p>YCL designed the experiments, performed the experiments, interpreted the results, and drafted the manuscript. WWC designed the experiments, provided samples and clinical data, interpreted the results and made critical revisions to the manuscript. Both authors have read and approved the final manuscript.</p>
      </fn>
    </fn-group>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jamieson</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Fuller</surname>
              <given-names>PJ</given-names>
            </name>
          </person-group>
          <article-title>Molecular pathogenesis of granulosa cell tumors of the ovary</article-title>
          <source>Endocr Rev</source>
          <year>2012</year>
          <volume>33</volume>
          <fpage>109</fpage>
          <lpage>144</lpage>
          <pub-id pub-id-type="doi">10.1210/er.2011-0014</pub-id>
          <pub-id pub-id-type="pmid">22240241</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Scully</surname>
              <given-names>RE</given-names>
            </name>
          </person-group>
          <article-title>Classification of human ovarian tumors</article-title>
          <source>Environ Health Perspect</source>
          <year>1987</year>
          <volume>73</volume>
          <fpage>15</fpage>
          <lpage>25</lpage>
          <pub-id pub-id-type="doi">10.1289/ehp.877315</pub-id>
          <pub-id pub-id-type="pmid">3665859</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Crum</surname>
              <given-names>CP</given-names>
            </name>
            <name>
              <surname>Nucci</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>KR</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Crum</surname>
              <given-names>CP</given-names>
            </name>
            <name>
              <surname>Nucci</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>KR</given-names>
            </name>
          </person-group>
          <article-title>Sex cord-stromal and miscellaneous tumors of the ovary</article-title>
          <source>Diagnostic Gynecology and Obstetrics Pathology</source>
          <year>2011</year>
          <publisher-loc>Philadelphia</publisher-loc>
          <publisher-name>Elsevier</publisher-name>
          <fpage>938</fpage>
          <lpage>971</lpage>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shah</surname>
              <given-names>SP</given-names>
            </name>
            <name>
              <surname>Kobel</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Senz</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Morin</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Clarke</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Wiegand</surname>
              <given-names>KC</given-names>
            </name>
            <name>
              <surname>Leung</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Zayed</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Mehl</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Kalloger</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Giuliany</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Yorida</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Varhol</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Swenerton</surname>
              <given-names>KD</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Clement</surname>
              <given-names>PB</given-names>
            </name>
            <name>
              <surname>Crane</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Madore</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Provencher</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Leung</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>DeFazio</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Khattra</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Turashvili</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Zeng</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Glover</surname>
              <given-names>JN</given-names>
            </name>
            <name>
              <surname>Vanderhyden</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mutation of FOXL2 in granulosa-cell tumors of the ovary</article-title>
          <source>N Engl J Med</source>
          <year>2009</year>
          <volume>360</volume>
          <fpage>2719</fpage>
          <lpage>2729</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJMoa0902542</pub-id>
          <pub-id pub-id-type="pmid">19516027</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schumer</surname>
              <given-names>ST</given-names>
            </name>
            <name>
              <surname>Cannistra</surname>
              <given-names>SA</given-names>
            </name>
          </person-group>
          <article-title>Granulosa cell tumor of the ovary</article-title>
          <source>J Clin Oncol</source>
          <year>2003</year>
          <volume>21</volume>
          <fpage>1180</fpage>
          <lpage>1189</lpage>
          <pub-id pub-id-type="doi">10.1200/JCO.2003.10.019</pub-id>
          <pub-id pub-id-type="pmid">12637488</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Amsterdam</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Selvaraj</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Control of differentiation, transformation, and apoptosis in granulosa cells by oncogenes, oncoviruses, and tumor suppressor genes</article-title>
          <source>Endocr Rev</source>
          <year>1997</year>
          <volume>18</volume>
          <fpage>435</fpage>
          <lpage>461</lpage>
          <pub-id pub-id-type="pmid">9267759</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ala-Fossi</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Maenpaa</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Aine</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Koivisto</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Koivisto</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Punnonen</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Prognostic significance of p53 expression in ovarian granulosa cell tumors</article-title>
          <source>Gynecol Oncol</source>
          <year>1997</year>
          <volume>66</volume>
          <fpage>475</fpage>
          <lpage>479</lpage>
          <pub-id pub-id-type="doi">10.1006/gyno.1997.4803</pub-id>
          <pub-id pub-id-type="pmid">9299263</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Roush</surname>
              <given-names>GR</given-names>
            </name>
            <name>
              <surname>El-Naggar</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Abdul-Karim</surname>
              <given-names>FW</given-names>
            </name>
          </person-group>
          <article-title>Granulosa cell tumor of ovary: a clinicopathologic and flow cytometric DNA analysis</article-title>
          <source>Gynecol Oncol</source>
          <year>1995</year>
          <volume>56</volume>
          <fpage>430</fpage>
          <lpage>434</lpage>
          <pub-id pub-id-type="doi">10.1006/gyno.1995.1076</pub-id>
          <pub-id pub-id-type="pmid">7705680</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schrader</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Gorbatcheva</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Senz</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Heravi-Moussavi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Melnyk</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Salamanca</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Maines-Bandiera</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Cooke</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Leung</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Brenton</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Gilks</surname>
              <given-names>CB</given-names>
            </name>
            <name>
              <surname>Monahan</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Huntsman</surname>
              <given-names>DG</given-names>
            </name>
          </person-group>
          <article-title>The specificity of the FOXL2 c.402C&#x2009;&gt;&#x2009;G somatic mutation: a survey of solid tumors</article-title>
          <source>PLoS One</source>
          <year>2009</year>
          <volume>4</volume>
          <fpage>e7988</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0007988</pub-id>
          <pub-id pub-id-type="pmid">19956657</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kittles</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Young</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Weinrich</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hudson</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Argyropoulos</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Ukoli</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Adams-Campbell</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Dunston</surname>
              <given-names>GM</given-names>
            </name>
          </person-group>
          <article-title>Extent of linkage disequilibrium between the androgen receptor gene CAG and GGC repeats in human populations: implications for prostate cancer risk</article-title>
          <source>Hum Genet</source>
          <year>2001</year>
          <volume>109</volume>
          <fpage>253</fpage>
          <lpage>261</lpage>
          <pub-id pub-id-type="doi">10.1007/s004390100576</pub-id>
          <pub-id pub-id-type="pmid">11702204</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>WC</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Ko</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Lai</surname>
              <given-names>YC</given-names>
            </name>
          </person-group>
          <article-title>Origin of uterine teratoma differs from that of ovarian teratoma: a case of uterine mature cystic teratoma</article-title>
          <source>Int J Gynecol Pathol</source>
          <year>2011</year>
          <volume>30</volume>
          <fpage>544</fpage>
          <lpage>548</lpage>
          <pub-id pub-id-type="doi">10.1097/PGP.0b013e31821c3205</pub-id>
          <pub-id pub-id-type="pmid">21979590</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sun</surname>
              <given-names>HD</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Jao</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>KL</given-names>
            </name>
            <name>
              <surname>Liou</surname>
              <given-names>WS</given-names>
            </name>
            <name>
              <surname>Hung</surname>
              <given-names>YC</given-names>
            </name>
            <name>
              <surname>Chiang</surname>
              <given-names>YC</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Lai</surname>
              <given-names>HC</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>MH</given-names>
            </name>
          </person-group>
          <article-title>A long-term follow-up study of 176 cases with adult-type ovarian granulosa cell tumors</article-title>
          <source>Gynecol Oncol</source>
          <year>2012</year>
          <volume>124</volume>
          <fpage>244</fpage>
          <lpage>249</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ygyno.2011.10.015</pub-id>
          <pub-id pub-id-type="pmid">22019525</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rosario</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Araki</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Print</surname>
              <given-names>CG</given-names>
            </name>
            <name>
              <surname>Shelling</surname>
              <given-names>AN</given-names>
            </name>
          </person-group>
          <article-title>The transcriptional targets of mutant FOXL2 in granulosa cell tumours</article-title>
          <source>PLoS One</source>
          <year>2012</year>
          <volume>7</volume>
          <fpage>e46270</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0046270</pub-id>
          <pub-id pub-id-type="pmid">23029457</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Suzuki</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ohwada</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Saga</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ochiai</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Sato</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>DNA replication error is frequent in ovarian granulosa cell tumors</article-title>
          <source>Cancer Genet Cytogenet</source>
          <year>2000</year>
          <volume>122</volume>
          <fpage>55</fpage>
          <lpage>58</lpage>
          <pub-id pub-id-type="doi">10.1016/S0165-4608(00)00269-7</pub-id>
          <pub-id pub-id-type="pmid">11104034</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Geiersbach</surname>
              <given-names>KB</given-names>
            </name>
            <name>
              <surname>Jarboe</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Jahromi</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Baker</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Paxton</surname>
              <given-names>CN</given-names>
            </name>
            <name>
              <surname>Tripp</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Schiffman</surname>
              <given-names>JD</given-names>
            </name>
          </person-group>
          <article-title>FOXL2 mutation and large-scale genomic imbalances in adult granulosa cell tumors of the ovary</article-title>
          <source>Cancer Genet</source>
          <year>2011</year>
          <volume>204</volume>
          <fpage>596</fpage>
          <lpage>602</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cancergen.2011.10.002</pub-id>
          <pub-id pub-id-type="pmid">22200085</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
